JACC This Week

Latest Episodes:

JACC - December 17 - 24, 2024 Issue Summary Dec 09, 2024

Show notes

In this episode, Dr. Valentin Fuster highlights five cutting-edge cardiology studies from the December 2024 issue of JACC, covering topics such as cardiac MRI's role in predicting sudden cardiac events in Fontan patients, the impact of oxidized phospholipids on calcific aortic valve disease, and the effects of renal and liver function on outcomes after tricuspid valve repair. With insights on mortality risks from influenza in heart failure patients and the outcomes of anatomical versus physiological repair for congenital heart defects, the episode offers a comprehensive look at critical advancements in cardiovascular care.

Cardiac MRI Predictors of Arrhythmic Sudden Cardiac Events in Patients with Fontan Circulation Dec 09, 2024

Show notes

In this episode, Dr. Valentin Fuster discusses a groundbreaking study on cardiac MRI predictors of arrhythmic sudden cardiac events in patients with Fontan circulation, highlighting key risk factors for these life-threatening incidents. The study, part of the multi-center FORCE registry, reveals significant findings, including the impact of clinical status and ventricular function, while emphasizing the importance of large-scale research in improving outcomes for single ventricle patients.

JACC - December 10, 2024 Issue Summary Dec 02, 2024

Show notes

In the December 2024 issue of JACC, Dr. Valentin Fuster summarizes five pivotal clinical studies, including one on bleeding and mortality following revascularization for left main coronary artery disease, which highlights higher bleeding rates post-CABG compared to PCI. Other key articles explore the use of the MitraClip in treating moderate-to-severe functional mitral regurgitation, evaluating its impact on hospitalization and quality of life, as well as comparing aspirin monotherapy to no antiplatelet therapy in patients undergoing low-risk non-cardiac surgery, and testing a novel low-dose triple pill for hypertension.

Major Bleeding and Mortality After Revascularization of Left Main Disease Dec 02, 2024

Show notes

In the December 10, 2024 JACC issue, a study from the EXCEL trial examines the link between bleeding complications and mortality in patients with left main coronary artery disease undergoing PCI or CABG. The findings highlight that while PCI showed lower rates of bleeding, both procedures had bleeding-related mortality risks, underscoring the need for strategies to minimize bleeding during and after revascularization.

Hospitalizations in Symptomatic Patients with Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights from RESHAPE-HF2 Dec 02, 2024

Show notes

In this episode, Dr. Valentin Fuster delves into the latest research surrounding the use of the mitral clip for patients with severe functional mitral regurgitation, comparing the results of three major trials: the French MITRA-FR trial, the American COAPT trial, and the Reshape HF 2 trial. While the COAPT and Reshape HF 2 trials show positive outcomes, especially in reducing hospitalizations and improving heart failure symptoms, the French trial saw no benefit, prompting debate over the influence of left ventricular volume and disease severity on treatment success, with expert opinions calling for further studies and individualized meta-analyses.

Percutaneous Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation in Heart Failure: A Meta-analysis of Randomized Controlled Trials Dec 02, 2024

Show notes

Aspirin Monotherapy versus No Antiplatelet Therapy in Stable Patients with Coronary Stents Undergoing Low-to-Intermediate Risk Non-cardiac Surgery Dec 02, 2024

Show notes

In this episode, Dr. Valentin Fuster discusses the ASSURE DES trial, which compared aspirin monotherapy to withholding antiplatelet therapy in stable patients with drug-eluting stents undergoing non-cardiac surgery. The trial found no significant difference in major adverse outcomes between the two strategies, though minor bleeding was more common in the aspirin group, leading to a recommendation to continue aspirin therapy for most patients undergoing low-to-intermediate risk surgery, with exceptions for those at high bleeding risk.

Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared with Placebo for Initial Treatment of Hypertension Dec 02, 2024

Show notes

In this podcast, Dr. Valentin Fuster discusses a groundbreaking study on the efficacy and safety of a novel low-dose triple combination pill for the initial treatment of hypertension. The study highlights how a single pill containing three blood pressure-lowering agents can significantly reduce blood pressure while improving patient adherence, offering a promising solution for hypertension management globally, especially in low-income settings.

Length of Hospital Stay for Endocarditis. Before and After Partial Oral Treatment of Endocarditis Trial Nov 25, 2024

Show notes

In this podcast, Dr. Valentin Fuster discusses a groundbreaking study published in JACC that examines the impact of the POET trial on the treatment of infective endocarditis. The study found that transitioning to oral antibiotic therapy after just 10 days of intravenous treatment reduced hospital stays by 8 days, without increasing mortality, and lowered relapse rates of bacteremia, suggesting a major shift toward oral antibiotics as a viable alternative to prolonged intravenous therapy.

Sudden Death in Obesity: Mechanisms and Management Nov 25, 2024

Show notes

In this podcast, Dr. Valentin Fuster introduces a state-of-the-art review on "Sudden Death in Obesity," exploring its mechanisms and management. Expert contributors from Cedars-Sinai Medical Center and Aalto University discuss key concepts, clinical characteristics, arrhythmia mechanisms, and therapeutic implications of this critical health issue.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

JACC This Week

Related Podcasts

1

2

3

4

5

6